カテゴリ： MarketLine, イギリス, 企業調査

Antofagasta Plc：企業の戦略・SWOT・財務情報

◆英語タイトル：Antofagasta Plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C4225
◆発行会社（調査会社）：MarketLine
◆発行日：2018年8月
◆ページ数：42
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：金属・鉱業
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Antofagasta Plc – Strategy, SWOT and Corporate Finance Report
Summary

Antofagasta Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Antofagasta plc (Antofagasta) is a global copper mining company. It explores, plans, builds, mines, processes, transports and markets a range of products, spanning bulk commodities and base metals. The company’s portfolio of mining assets and resources include copper, gold, molybdenum and silver. It is also the principal provider of cargo transport in the Antofagasta region in the north of Chile. The company’s products are used in infrastructure, automotive, engineering, steel manufacturing and other applications. Its activities are mainly concentrated in Chile. The company operates in Europe, Latin America, North America, and Asia Pacific. It is headquartered in London, the UK.

Scope

- Detailed information on Antofagasta Plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Antofagasta Plc in the form of a SWOT analysis
- An in-depth view of the business model of Antofagasta Plc including a breakdown and examination of key business segments
- Intelligence on Antofagasta Plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Antofagasta Plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Antofagasta Plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Antofagasta Plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Antofagasta Plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Antofagasta Plc: Company Overview 9
Antofagasta Plc: Overview and Key Facts 9
Antofagasta Plc: Overview 9
Antofagasta Plc: Key Facts 9
Antofagasta Plc: Key Employees 11
Antofagasta Plc: Key Employee Biographies 12
Antofagasta Plc: Major Products and Services 13
Antofagasta Plc: Company History 14
Antofagasta Plc: Management Statement 18
Antofagasta Plc: Locations and Subsidiaries 22
Antofagasta Plc: Key Competitors 23
Antofagasta Plc: Company Analysis 24
Antofagasta Plc: Business Description 24
Antofagasta Plc: SWOT Analysis 25
Antofagasta Plc: SWOT Overview 25
Antofagasta Plc: Strengths 25
Antofagasta Plc: Weaknesses 26
Antofagasta Plc: Opportunities 26
Antofagasta Plc: Threats 27
Antofagasta Plc: Corporate Financial Deals Activity 28
Antofagasta Plc: Financial Deals Overview 28
Antofagasta Plc: Targets and Partners 29
Antofagasta Plc: Top Deals 2014 – 2018YTD* 30
Antofagasta Plc: Advisors 31
Antofagasta Plc: Top Legal Advisors 31
Antofagasta Plc: Top Financial Advisors 31
Antofagasta Plc: Mergers and Acquisitions 32
Antofagasta Plc: Divestments 33
Antofagasta Plc: Recent Developments 34
Antofagasta Plc: News and Events Summary 34
Antofagasta Plc: Financial Performance 36
Antofagasta Plc: Regulatory and Legal Events 36
Antofagasta Plc: Strategy and Operations 37
Appendix 40
Contact Us 40
Methodology 40
About MarketLine 41

List of Tables
Table 1: Antofagasta Plc: Key Facts
Table 2: Antofagasta Plc: Key Employees
Table 3: Antofagasta Plc: Locations and Subsidiaries
Table 4: Antofagasta Plc: Key Competitors
Table 5: Antofagasta Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Antofagasta Plc: M&A Average Deal Size - Value (US$m)
Table 7: Antofagasta Plc: Targets and Partners
Table 8: Antofagasta Plc: Top Deals 2014 - 2018YTD*
Table 9: Antofagasta Plc: Legal Advisor Ranking by Value (US$m)
Table 10: Antofagasta Plc: Financial Advisor Ranking by Value (US$m)
Table 11: Antofagasta Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: Antofagasta Plc: M&A Activity by Geography (2014 - YTD*2018)
Table 13: Antofagasta Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 14: Antofagasta Plc: Divestments by Geography (2014 - YTD*2018)
Table 15: Antofagasta Plc: News and Events Summary
Table 16: Antofagasta Plc: Financial Performance
Table 17: Antofagasta Plc: Regulatory and Legal Events
Table 18: Antofagasta Plc: Strategy and Operations

List of Figures
Figure 1: Antofagasta Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Antofagasta Plc: M&A Average Deal Size - Value (US$m)
Figure 3: Antofagasta Plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 4: Antofagasta Plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 5: Antofagasta Plc: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 6: Antofagasta Plc: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Antofagasta Plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • MicuRx Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary MicuRx Pharmaceuticals Inc (MicuRx) is a developer of antibiotics for drug-resistant bacterial infections. The company develops a pipeline of antimicrobial agents using its proprietary drug discovery platform to treat both gram-positive and gram-negative bacterial infections. It offers produ …
  • Noble Corporation Plc (NE)：企業の財務・戦略的SWOT分析
    Noble Corporation Plc (NE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Armune BioScience Inc：製品パイプライン分析
    Summary Armune BioScience Inc (Armune) is a medical device company that develops and commercializes molecular diagnostic and prognostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests fo …
  • Emirates Flight Catering：企業の戦略・SWOT・財務分析
    Emirates Flight Catering - Strategy, SWOT and Corporate Finance Report Summary Emirates Flight Catering - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BioStar Pharmaceuticals Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary BioStar Pharmaceuticals Inc (BioStar) is a developer, manufacturer and marketer of pharmaceutical and healthcare supplement products for various diseases and conditions. The company offers products such as huangyangning tablets, hyperthyroidism capsules, danshen granule, aoxing oleanolic aci …
  • Versantis AG：製薬・医療：M&Aディール及び事業提携情報
    Summary Versantis AG (Versantis) is a pharmaceutical company that develops new generation of medicines and diagnostics for treating patients with liver diseases. The company’s pipeline product includes VS-01, a liposomal-based peritoneal dialysis fluid that acts as a clearance enhancer for a large s …
  • Gulfport Energy Corp (GPOR)：企業の財務・戦略的SWOT分析
    Gulfport Energy Corp (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Devon Energy Corporation：企業の戦略・SWOT・財務情報
    Devon Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Devon Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Siam Makro Public Company Limited (MAKRO)：企業の財務・戦略的SWOT分析
    Siam Makro Public Company Limited (MAKRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Frequency Therapeutics Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Frequency Therapeutics Inc (Frequency Therapeutics) is a biotechnology company that develops progenitor cell activation (PCA) therapies. The company’s small molecule drugs are used to activate progenitor cells for restoration of healthy tissue. Its lead program FX-322 is used to recreate sen …
  • Greencore Group Plc：戦略・SWOT・企業財務分析
    Greencore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Greencore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • VIDA Diagnostics Inc：医療機器：M&Aディール及び事業提携情報
    Summary VIDA Diagnostics Inc (VIDA) is a medical technology company that provides clinical imaging software and analysis services for early detection, evaluation, and treatment of pulmonary diseases. The company offers VIDA exchange and VIDA vision. Its products are used in airway mapping, lung volu …
  • PolyNovo Biomaterials Pty Ltd：企業の製品パイプライン分析2018
    Summary PolyNovo Biomaterials Pty Ltd (PolyNovo), a subsidiary of PolyNovo Ltd is a medical technology company that develops, designs and manufactures controlled bioeroding tissue and orthopedic solutions. The company’s Novosorb polymers are based on polyurethanes, a polymer family used in medical a …
  • Tiger Brands Ltd (TBS)：企業の財務・戦略的SWOT分析
    Tiger Brands Ltd (TBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Konami Holdings Corp：企業の戦略・SWOT・財務情報
    Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report Summary Konami Holdings Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hafslund ASA：企業の戦略的SWOT分析
    Hafslund ASA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Burnet Institute：製薬・医療：M&Aディール及び事業提携情報
    Summary Burnet Institute is a non-profit and independent organization that improves health of poor and vulnerable communities through research, education and public health. The institute offers solutions to major health issues through development and discovery of novel vaccines, diagnostic tests and …
  • Claris Lifesciences Ltd (533288)-製薬・医療分野：企業M&A・提携分析
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company offers generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. Its products are offered through various delivery sys …
  • Sheraton Seoul Palace：企業の戦略・SWOT・財務分析
    Sheraton Seoul Palace - Strategy, SWOT and Corporate Finance Report Summary Sheraton Seoul Palace - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Breg Inc-医療機器分野：企業M&A・提携分析
    Summary Breg Inc (Breg) is a medical device company that manufactures and distributes cold therapy products. The company offers products, which include cold therapy products, hip braces, elbow or wrist braces, knee braces, shoulder braces, spine braces, ankle braces, home therapy kits, and others. I …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆